NGGT (Suzhou) Biotechnology Co., Ltd.
NGGT (Suzhou) Biotechnology Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of NGGT002 in Adult Patients With Phenylketonuria | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, phenylketonuria | Recruiting | Phase 1 / Phase 2 | 2026-08-13 | NCT06687733 | |
| Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy Subjects | Bietti crystalline corneoretinal dystrophy | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-12 | NCT06706427 |